THE SENSITIVITY OF A VOLUNTARY DRUG EXPERIENCE REPORTING SYSTEM

被引:1
作者
HOWSE, CR
LINDEN, CV
BARRY, WS
机构
来源
DRUG INTELLIGENCE & CLINICAL PHARMACY | 1980年 / 14卷 / 06期
关键词
D O I
10.1177/106002808001400612
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:439 / 440
页数:2
相关论文
共 7 条
[1]  
BOMAN G, 1978, COMPUTER AID DRUG TH, P115
[2]   ADVERSE DRUG EFFECTS AND THEIR IMPACT ON PATIENT-CARE - REVIEW OF THE PROBLEM [J].
BURKHOLDER, DF .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1979, 13 (7-8) :421-424
[3]  
DUNNE JF, 1978, COMPUTER AID DRUG TH, P105
[4]  
FARINA JC, 1978, C COMPUTER AID DRUG, P117
[5]  
MCQUEEN EG, 1977, DRUG MONITORING, P11
[6]   POST-MARKETING SURVEILLANCE OF NEW DRUGS .1. REVIEW OF OBJECTIVES AND METHODOLOGY [J].
WARDELL, WM ;
TSIANCO, MC ;
ANAVEKAR, SN ;
DAVIS, HT .
JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 19 (2-3) :85-94
[7]  
1979, IMS PHARMACEUTIC NOV, P8